ARCHIVES

In Brief: Thomas Jordan Promoted At Bristol-Myers, Markison To Succeed Him In Oncology Div.

This article is from The Cancer Letter archive.

Vol. 18 No. 09 | February 28, 1992

Download PDF Visit The Full Archive

Related Articles

RFPs Available, Contract Awards, Sole Source Negotiations

June 25, 1976

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

Senate Vote On Override Of NIH Reauthorization Veto Delayed Until After US-USSR Summit Meeting

November 22, 1985

In Brief: Griesemer Returns To NIEHS to Head Toxicology Research & Testing; Robert Burnight Dies at 69

August 12, 1988

Rauscher Delays Decision Until June 30

June 11, 1976

Radiotherapy In Combination With Zometa Provide Pain Control For Advanced Myeloma

February 27, 2004